Breast cancer: a call for papers.

摘要

In many countries the probability of developing a cancer before the age of 65 years is fast approaching 15%. This is a substantial risk and of all cancers, breast neoplasia is the most prevalent, not only in women but also overall. The Lancet Oncology is, therefore, issuing a call for papers that will offer major advances in the management of breast cancer. In particular, we are interested in the results of phase III randomised controlled trials. Accepted papers will be published in The Lancet Oncology to coincide with the San Antonio Breast Cancer Symposium (SABCS; TX, USA, Dec 13-16, 2007). We are especially interested in research that will be presented at this conference, but we will also consider other suitable articles. If your submission describes, in part or wholly, a study accepted for presentation at the SABCS, please let us know the precise details of the type of presentation (such as poster or oral presentation), including dates and times, so that publication in The Lancet Oncology can be scheduled to comply with SABCS's embargo policies. Articles should be submitted via The Lancet Oncology's online submission service, and all authors must clearly state in the covering letter that their submission is in response to the "SABCS Call for Papers". The deadline for submissions is Oct 12, 2007.